TECH-INNO Health

Tech-Inno Health (Beijing) Technology Co., Ltd. is a specialized biotechnology firm headquartered in Beijing, China, focusing on the in vitro diagnostics (IVD) market. Since its inception in 2010, the company has developed a robust portfolio of point-of-care testing (POCT) solutions and automated chemiluminescence immunoassay (CLIA) systems. Their flagship MQ-series analyzers are designed for high-sensitivity detection of various biomarkers, including cardiac markers, inflammatory indicators, and infectious disease antigens. Tech-Inno Health's products are widely utilized in clinical laboratories and emergency departments to provide rapid and accurate diagnostic results. The company is committed to advancing medical diagnostics through continuous innovation in microfluidics and immunoassay technologies. With a global distribution network, Tech-Inno Health supports healthcare providers in improving patient outcomes through timely intervention.